Cargando…
Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model
INTRODUCTION: Stroke is the second leading cause of death worldwide, claims six lives every 60 seconds, and is a leading cause of adult disability across the globe. Tissue plasminogen activator, the only United States Food and Drug Administration (FDA)-approved drug currently available, has a narrow...
Autores principales: | Karlupia, Neha, Manley, Nathan C, Prasad, Kameshwar, Schäfer, Richard, Steinberg, Gary K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055161/ https://www.ncbi.nlm.nih.gov/pubmed/24690461 http://dx.doi.org/10.1186/scrt434 |
Ejemplares similares
-
Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function
por: Huang, Lei, et al.
Publicado: (2017) -
Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism
por: Lv, Yong-Tao, et al.
Publicado: (2013) -
Human umbilical cord mesenchymal stromal cells in regenerative medicine
por: Detamore, Michael S
Publicado: (2013) -
Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications
por: Russo, E., et al.
Publicado: (2022) -
Umbilical cord mesenchymal stromal cells—from bench to bedside
por: Chetty, Shashank, et al.
Publicado: (2022)